These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 29349622)
21. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy. Voravud N; Sriuranpong V J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676 [TBL] [Abstract][Full Text] [Related]
22. Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy. Quirt I; Robeson C; Lau CY; Kovacs M; Burdette-Radoux S; Dolan S; Tang SC; McKenzie M; Couture F; J Clin Oncol; 2001 Nov; 19(21):4126-34. PubMed ID: 11689580 [TBL] [Abstract][Full Text] [Related]
23. Cancer-related fatigue: clinical practice versus practice guidelines. Hilarius DL; Kloeg PH; van der Wall E; Komen M; Gundy CM; Aaronson NK Support Care Cancer; 2011 Apr; 19(4):531-8. PubMed ID: 20238129 [TBL] [Abstract][Full Text] [Related]
24. Educational interventions encouraging appropriate use of blood transfusions. Abelow A; Gafter-Gvili A; Tadmor B; Lahav M; Shepshelovich D Vox Sang; 2017 Feb; 112(2):150-155. PubMed ID: 28176346 [TBL] [Abstract][Full Text] [Related]
25. Changes in the use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes. Gawade PL; Berlin JA; Henry DH; Tomita D; Brooks BD; Franklin J; Bradbury BD; Critchlow CW Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1357-1366. PubMed ID: 28809079 [TBL] [Abstract][Full Text] [Related]
26. Hematologic outcomes and blood utilization in cancer patients with chemotherapy-induced anemia (CIA) pre- and post-national coverage determination (NCD): results from a multicenter chart review. Henry DH; Langer CJ; McKenzie RS; Piech CT; Senbetta M; Schulman KL; Stepanski EJ Support Care Cancer; 2012 Sep; 20(9):2089-96. PubMed ID: 22160485 [TBL] [Abstract][Full Text] [Related]
28. Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks. Gabrilove JL; Perez EA; Tomita DK; Rossi G; Cleeland CS Cancer; 2007 Oct; 110(7):1629-40. PubMed ID: 17694552 [TBL] [Abstract][Full Text] [Related]
29. Transfusions of packed red blood cells in surgery for liver cancer: predictor of impaired overall survival but not recurrence-free survival - impact of blood transfusions in liver surgery. Giehl-Brown E; Geipel E; Löck S; Dehlke K; Schweipert J; Weitz J; Riediger C J Gastrointest Surg; 2024 Apr; 28(4):402-411. PubMed ID: 38583890 [TBL] [Abstract][Full Text] [Related]
30. Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study. Aerts JG; Swieboda-Sadlej A; Karanikiotis C; Labourey JL; Galid A; Wheeler T; Pujol B; Van Belle S Curr Med Res Opin; 2012 Jul; 28(7):1089-99. PubMed ID: 22642866 [TBL] [Abstract][Full Text] [Related]
32. The effect of time on packed cell volume following packed red blood cell transfusion in anemic dogs. Morris JL; Bloch CP; Brabson TL J Vet Emerg Crit Care (San Antonio); 2021 Mar; 31(2):215-220. PubMed ID: 33118669 [TBL] [Abstract][Full Text] [Related]
33. [Blood transfusion in intensive care: an epidemiological observational study]. Rocco JR; Soares M; Espinoza RA Rev Bras Ter Intensiva; 2006 Sep; 18(3):242-50. PubMed ID: 25310437 [TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. Gabrilove JL; Cleeland CS; Livingston RB; Sarokhan B; Winer E; Einhorn LH J Clin Oncol; 2001 Jun; 19(11):2875-82. PubMed ID: 11387360 [TBL] [Abstract][Full Text] [Related]
35. Influence of cross-match on posttransfusion packed cell volume in feline packed red blood cell transfusion. Weltman JG; Fletcher DJ; Rogers C J Vet Emerg Crit Care (San Antonio); 2014; 24(4):429-36. PubMed ID: 25039745 [TBL] [Abstract][Full Text] [Related]
36. [Frequency of blood transfusions for anemia caused by chemotherapy in ovarian cancer patients. Thoughts about the guidelines modified in 2006 for the treatment of anemic cancer patients by the European Organisation for Research and Treatment of Cancer]. Lehoczky O; Pulay T Orv Hetil; 2007 Nov; 148(45):2133-7. PubMed ID: 17984024 [TBL] [Abstract][Full Text] [Related]
37. Chemotherapy-induced anemia in adults: incidence and treatment. Groopman JE; Itri LM J Natl Cancer Inst; 1999 Oct; 91(19):1616-34. PubMed ID: 10511589 [TBL] [Abstract][Full Text] [Related]
38. National Benchmarks for Proportions of Patients Receiving Blood Transfusions During Pediatric and Congenital Heart Surgery: An Analysis of the STS Congenital Heart Surgery Database. Kartha VM; Jacobs JP; Vener DF; Hill KD; Goldenberg NA; Pasquali SK; Meza JM; O'Brien SM; Feng L; Chiswell K; Eghtesady P; Badhwar V; Rehman M; Jacobs ML Ann Thorac Surg; 2018 Oct; 106(4):1197-1203. PubMed ID: 29902465 [TBL] [Abstract][Full Text] [Related]
39. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. Littlewood TJ; Bajetta E; Nortier JW; Vercammen E; Rapoport B; J Clin Oncol; 2001 Jun; 19(11):2865-74. PubMed ID: 11387359 [TBL] [Abstract][Full Text] [Related]
40. Changes in the hemoglobin level after one unit of packed red blood cell transfusion in Intensive Care Unit patients. Kashefi P; Rahmani A; Khalifesoltani M J Res Med Sci; 2018; 23():85. PubMed ID: 30294353 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]